Lexeo Therapeutics, Inc. (LXEO)
2.76
-0.14
(-4.99%)
USD |
NASDAQ |
Nov 06, 10:31
Lexeo Therapeutics EPS Diluted (Quarterly) : -0.3021 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3021 |
| March 31, 2026 | -0.2488 |
| December 31, 2025 | -0.274 |
| September 30, 2025 | -0.3326 |
| June 30, 2025 | -0.5991 |
| March 31, 2025 | -0.9862 |
| December 31, 2024 | -0.7838 |
| September 30, 2024 | -0.8919 |
| June 30, 2024 | -0.6435 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.7749 |
| December 31, 2023 | -0.5325 |
| September 30, 2023 | -0.7546 |
| June 30, 2023 | -0.5044 |
| March 31, 2023 | -0.7002 |
| December 31, 2022 | -0.547 |
| September 30, 2022 | -0.64 |
| June 30, 2022 | -0.5683 |
| March 31, 2022 | -0.4692 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.87M |
| Total Expenses (Quarterly) | 25.87M |
| Enterprise Value | 23.51M |
| Earnings Yield | -41.94% |
| Normalized Earnings Yield | -41.93 |